Loading...
Amplifon S.p.A.
AMFPF•PNK
Healthcare
Medical - Distribution
$23.85
$0.00(0.00%)
Amplifon S.p.A. (AMFPF) Financial Performance & Statements
Review Amplifon S.p.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
6.60%
↑ 6.60%
Operating Income Growth
-3.23%
↓ 3.23%
Net Income Growth
-6.29%
↓ 6.29%
Operating Cash Flow Growth
8.66%
↑ 8.66%
Operating Margin
10.61%
↑ 10.61%
Gross Margin
53.67%
↑ 53.67%
Net Profit Margin
6.05%
↑ 6.05%
ROE
12.80%
↑ 12.80%
ROIC
9.04%
↑ 9.04%
Amplifon S.p.A. (AMFPF) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Amplifon S.p.A. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $664.40M | $572.74M | $604.14M | $573.11M |
| Cost of Revenue | -$296.77M | $453.54M | $518.26M | $510.14M |
| Gross Profit | $961.17M | $119.20M | $85.88M | $62.97M |
| Gross Profit Ratio | $1.45 | $0.21 | $0.14 | $0.11 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $886.75M | $4.21M | $0.00 | $0.00 |
| Operating Expenses | $886.75M | $79.66M | $73.64M | $70.54M |
| Total Costs & Expenses | $511.10M | $534.15M | $518.26M | $510.14M |
| Interest Income | $2.35M | $0.00 | $0.00 | $0.00 |
| Interest Expense | $17.78M | $15.29M | $12.50M | $13.14M |
| Depreciation & Amortization | $81.77M | $75.45M | $73.64M | $70.54M |
| EBITDA | $153.06M | $113.25M | $157.11M | $133.86M |
| EBITDA Ratio | $0.23 | $0.20 | $0.26 | $0.23 |
| Operating Income | $69.28M | $38.59M | $85.88M | $62.97M |
| Operating Income Ratio | $0.10 | $0.07 | $0.14 | $0.11 |
| Other Income/Expenses (Net) | -$16.44M | -$16.09M | -$13.06M | -$12.79M |
| Income Before Tax | $52.84M | $22.51M | $70.97M | $50.18M |
| Income Before Tax Ratio | $0.08 | $0.04 | $0.12 | $0.09 |
| Income Tax Expense | $11.58M | $6.07M | $18.71M | $14.85M |
| Net Income | $41.19M | $16.77M | $52.93M | $34.86M |
| Net Income Ratio | $0.06 | $0.03 | $0.09 | $0.06 |
| EPS | $0.18 | $0.07 | $0.23 | $0.15 |
| Diluted EPS | $0.18 | $0.07 | $0.23 | $0.15 |
| Weighted Avg Shares Outstanding | $225.14M | $230.14M | $226.18M | $225.79M |
| Weighted Avg Shares Outstanding (Diluted) | $225.14M | $230.14M | $228.11M | $227.22M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan